BeOne Medicines Ltd.
BeOne Medicines Ltd. (ONC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
onc · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for BeOne Medicines Ltd. (ONC) measures how much investors pay for each dollar of the company's trailing earnings. ONC's current PE ratio of 88.58x is calculated by dividing its stock price of $270.10 by its TTM earnings per share of $0.36. −23.3% discount vs 5Y avg 115.5x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2013 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Pharmaceuticals · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
BeOne Medicines Ltd.You ONC | $28.9B | 88.58x | +207.5% | $0.36 |
 Agilent Technologies, Inc. A | $38.3B | 31.79x | +10.4% | $4.60 |
 Alcon Inc. ALC | $32.6B | 39.80x | +38.2% | $1.98 |
 GE HealthCare Technologies Inc. GEHC | $29.4B | 17.97x | -37.6% | $4.56 |
 Humana Inc. HUM | $42.0B | 25.97x | -9.8% | $9.86 |
 Insmed Incorporated INSM | $20.4B | N/A | — | -$5.98 |
 IQVIA Holdings Inc. IQV | $30.6B | 28.49x | -1.1% | $7.91 |
Industry Average 5 peers with valid PE | — | 28.80x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 115.48x | $2.63 | — | |
2024-12-31 FY2024 | — | $-6.12 | — | |
2023-12-31 FY2023 | — | $-8.45 | — | |
2022-12-31 FY2022 | — | $-19.43 | — | |
2021-12-31 FY2021 | — | $-15.71 | — | |
2020-12-31 FY2020 | — | $-19.47 | — | |
2019-12-31 FY2019 | — | $-15.80 | — | |
2018-12-31 FY2018 | — | $-12.15 | — | |
2017-12-31 FY2017 | — | $-2.23 | — | |
2016-12-31 FY2016 | — | $-3.84 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for BeOne Medicines Ltd. (ONC) measures how much investors pay for each dollar of the company's trailing earnings. ONC's current PE ratio of 88.58x is calculated by dividing its stock price of $270.10 by its TTM earnings per share of $0.36.
Frequently asked questions
ONC pe ratio · 6 questionsONC's current PE ratio is 88.58x as of 2026-06-08, based on a stock price of $270.10 and TTM EPS of $0.36. Data sourced from Financial Modeling Prep via ONC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · BeOne Medicines Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08